Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
In the last 90 days, Emergent BioSolutions Inc. insiders filed 0 open-market purchases and 1 sale; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Emergent BioSolutions Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 194
- +6 vs. Q1 2026
- Shares held
- 44.6M
- +1.18M (+2.7%) vs. Q1 2026
- Total value
- $373.6M
- +$13.2M (+3.7%) vs. Q1 2026
- New holders
- 32
- 68 more added
- Sold out
- 26
- 63 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EBS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 194 | $373.6M |
| Q1 2026 | 190 | $360.7M |
| Q4 2025 | 183 | $536.5M |
| Q3 2025 | 169 | $352.5M |
| Q2 2025 | 161 | $240.9M |
| Q1 2025 | 161 | $176.1M |
| Q4 2024 | 156 | $332.0M |
| Q3 2024 | 140 | $264.5M |
| Q2 2024 | 141 | $207.5M |
| Q1 2024 | 121 | $90.8M |
| Q4 2023 | 134 | $98.2M |
| Q3 2023 | 163 | $140.8M |
| Q2 2023 | 183 | $336.2M |
| Q1 2023 | 192 | $465.3M |
| Q4 2022 | 198 | $545.8M |
| Q3 2022 | 211 | $852.4M |
| Q2 2022 | 233 | $1.28B |
| Q1 2022 | 254 | $1.72B |
| Q4 2021 | 254 | $1.86B |
| Q3 2021 | 277 | $2.23B |
| Q2 2021 | 290 | $2.82B |
| Q1 2021 | 340 | $4.14B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Emergent BioSolutions Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −33,620−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −19,386−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −18,149−100.0% | Sold out |
| Vise Technologies, Inc. | 0 | $0 | 0.00% | −10,582−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −15,752−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,113−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −11,056−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −10,710−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −10,106−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −15,337−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −1,773−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −461−100.0% | Sold out |
| Intentional Wealth Strategies, LLC | 0 | $0 | 0.00% | −357−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −274−100.0% | Sold out |
| Dogwood Wealth Management LLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Bayban | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |